Adaptable Proanthocyanidin Polymer Compositions for Congenital Diarrhea Disorder Treatment in Specialized Environments

Publication ID: 24-11857510_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable Proanthocyanidin Polymer Compositions for Congenital Diarrhea Disorder Treatment in Specialized Environments,” Published Technical Disclosure No. 24-11857510_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857510_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,510.

Summary of the Inventive Concept

This inventive concept adapts proanthocyanidin polymer compositions for treating congenital diarrhea disorder to specific, niche environments, including disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration.

Background and Problem Solved

The original patent disclosed methods and compositions for treating congenital diarrhea disorder using proanthocyanidin polymer compositions. However, these compositions were not designed to address the unique challenges of specific, high-stress environments. This inventive concept solves the problem of adapting these compositions for use in disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration, where traditional formulations may be ineffective or impractical.

Detailed Description of the Inventive Concept

The inventive concept comprises proanthocyanidin polymer compositions specifically designed for use in specialized environments. These compositions may be formulated in portable, waterproof containers for disaster relief, secure, tamper-evident containers for high-security facilities, heat-stable, freeze-dried formulations for extreme weather conditions, or microgravity-compatible, hermetically sealed containers for space exploration. Additionally, the inventive concept may include portable kits for remote, off-grid locations, comprising a proanthocyanidin polymer composition, a water purification system, and a solar-powered refrigeration unit. These adaptations enable effective treatment of congenital diarrhea disorder in a variety of challenging environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of proanthocyanidin polymer compositions for specific, niche environments, which is not addressed by the original patent. The inventive step is the recognition of the need for specialized formulations and packaging to address the unique challenges of these environments, and the development of compositions and systems that meet these needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include formulations adapted for use in other specialized environments, such as tropical or desert environments, or for use in conjunction with other medical treatments. Variations may include different proanthocyanidin polymer compositions, alternative packaging materials or designs, or integration with other medical devices or systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of disaster relief, high-security healthcare, and space exploration. The market for these specialized compositions and systems is likely to be niche, but high-value, and may include government agencies, non-governmental organizations, and private companies operating in these environments.

CPC Classifications

SectionClassGroup
A A61 A61K31/353
A A61 A61K9/0095
A A61 A61K9/28
A A61 A61K9/48
A A61 A61P1/04
A A61 A61P1/12

Field of Art

Pharmaceutical compositions and medical treatment methods, specifically focused on gastrointestinal disorders, with expertise in drug formulation, delivery systems, and specialized medical interventions

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or medical researcher with advanced degrees in pharmacy, biochemistry, or medical sciences, possessing knowledge of drug delivery technologies, formulation strategies, and clinical treatment adaptations

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's proanthocyanidin polymer composition for treating congenital diarrhea disorder provides a foundational framework that can be readily adapted to various environmental contexts. The PTD's variations represent predictable extensions of the original treatment method, applying known pharmaceutical formulation and packaging techniques to address specific use scenarios. The core therapeutic mechanism remains unchanged, with modifications focusing on delivery and preservation strategies that are well within the capabilities of a skilled practitioner.

Obvious Combinations & Variations

Source Patent Element
Proanthocyanidin polymer composition for treating congenital diarrhea in infants
PTD Variation
Disaster relief portable, waterproof container formulation
Obviousness Reasoning
Adapting pharmaceutical packaging for extreme conditions is a standard design choice in medical product development, representing a predictable solution to environmental challenges
Source Patent Element
Method of administering composition to subjects requiring specialized medical intervention
PTD Variation
Space exploration microgravity-compatible hermetically sealed container
Obviousness Reasoning
Modifying drug delivery systems for unique environmental constraints is a routine engineering task with known techniques for maintaining pharmaceutical stability and efficacy
Source Patent Element
Treatment method for congenital diarrheal disorders
PTD Variation
Remote off-grid location kit with water purification and solar refrigeration
Obviousness Reasoning
Integrating pharmaceutical treatments with auxiliary support technologies represents a logical extension of medical product design, addressing practical limitations in resource-constrained environments
Source Patent Element
Composition for treating secretory diarrhea in infant subjects
PTD Variation
High-security facility tamper-evident container design
Obviousness Reasoning
Implementing specialized containment strategies is a standard approach in pharmaceutical security and transportation, representing an obvious variation to a skilled practitioner
Source Patent Element
Proanthocyanidin polymer composition with heat-sensitive properties
PTD Variation
Heat-stable, freeze-dried formulation for extreme weather conditions
Obviousness Reasoning
Developing alternative formulation strategies to enhance drug stability is a predictable solution in pharmaceutical science, particularly for temperature-sensitive compounds
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857510 and the disclosed variations, a person having ordinary skill in the art would find the proposed technical adaptations obvious and non-inventive. The PTD demonstrates that the core therapeutic method can be readily modified through standard pharmaceutical engineering techniques without requiring innovative conceptual leaps, thus rendering potential derivative claims obvious and anticipatable as prior art.

Original Patent Information

Patent NumberUS 11,857,510
TitleMethods and compositions for treating congenital diarrhea disorder
Assignee(s)NAPO PHARMACEUTICALS, INC.